+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Drug Market by Animal Type, Product Category, Route Of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Veterinary Drug Market by Animal Type, Product Category, Route Of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Veterinary Drug Market by Animal Type, Product Category, Route Of Administration, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986087
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Drug Market grew from USD 24.39 billion in 2024 to USD 25.91 billion in 2025. It is expected to continue growing at a CAGR of 6.01%, reaching USD 34.62 billion by 2030.

Setting the Stage for Veterinary Therapeutics Innovation

The veterinary drug sector occupies a critical nexus between animal welfare, public health imperatives, and global food security. Increasing concerns about zoonotic diseases and antimicrobial resistance have elevated the strategic importance of therapies designed for aquatic, companion, equine, livestock, and poultry species. Rapid advances in biotechnology and data analytics are redefining how safe and effective treatments are developed, regulated, and deployed across diverse veterinary settings.

Against this backdrop, decision-makers require a holistic, evidence-based view of the forces shaping market dynamics. This executive summary synthesizes the most significant developments in regulatory frameworks, supply chain resilience, and R&D innovation. It highlights key shifts in cost structures, stakeholder expectations, and distribution networks that influence the availability and affordability of veterinary medicines.

By unpacking transformative trends, assessing the implications of United States tariff adjustments slated for 2025, and providing targeted segmentation and regional analyses, this overview equips leaders with the knowledge needed to refine strategies, optimize portfolios, and capitalize on emerging growth opportunities across the veterinary therapeutics landscape.

Emerging Disruptors Reshaping the Veterinary Drug Arena

Technological breakthroughs and evolving stakeholder priorities are fundamentally reshaping the veterinary drug arena. Precision medicine initiatives leverage genomic profiling to target pathogens more effectively, while digital platforms enable remote diagnosis, treatment monitoring, and real-time data collection. These innovations expand access to care in underserved regions and enhance treatment compliance among pet owners and agricultural producers.

Meanwhile, mounting pressure to reduce antibiotic use has accelerated research into alternative modalities such as novel biologics, phage therapy, and vaccines engineered for species-specific safety profiles. Sustainability imperatives are driving investment in manufacturing processes that lower environmental footprints and adhere to circular economy principles. At the same time, resilience-focused supply chain strategies are being adopted to mitigate disruptions, from port congestions to raw material shortages.

Collectively, these disruptors demand that stakeholders rethink traditional value chains. From early-stage discovery through post-market surveillance, veterinary drug developers and distributors are adopting agile methodologies and forging cross-sector partnerships. As a result, the industry is entering a new era marked by faster product cycles, deeper collaboration, and a sharper alignment of therapeutic goals with end-user expectations.

Tariff Shifts in 2025 and Their Cascading Effects on Veterinary Drug Trade

The introduction of revised United States tariffs in 2025 has sent ripples through global veterinary drug supply chains. Increased duties on key APIs and finished formulations imported from major manufacturing hubs have elevated landed costs, prompting purchasers to reevaluate sourcing strategies. In turn, some distributors are recalibrating procurement mixes toward domestically produced or tariff-exempt goods to preserve margin structures.

Beyond direct cost escalations, the tariff revisions have catalyzed strategic realignments. Contract manufacturers are exploring relocation or capacity expansion within tariff-friendly jurisdictions, while regulatory affairs teams are prioritizing filings that support expedited local approval processes. Although these shifts introduce short-term complexity, they also open pathways for domestic industry growth and enhanced supply security in the long term.

Unveiling Market Segmentation Dynamics Driving Veterinary Medicine Demand

An in-depth look at animal categories reveals distinct demand drivers across production and companion segments. Aquaculture treatments for fish and shrimp are increasingly tailored to intensive farming systems, where water quality challenges and biosecurity concerns require specialized therapies. In the companion space, rising expenditures on canine and feline wellness are fueling innovation in chronic disease management and preventative care. Meanwhile, equine practitioners emphasize performance enhancement and injury recovery, creating niche opportunities for targeted formulations. Livestock sectors, encompassing cattle, small ruminants, and swine, continue to pursue cost-efficient broad-spectrum anti-infectives and growth promoters, whereas poultry operators focus on vaccines and parasiticides optimized for chickens and turkeys.

Product differentiation also plays a pivotal role. The demand for anti-infectives spans traditional antibiotics alongside emerging antifungal and antiviral agents. Antibiotic subclasses such as cephalosporins, fluoroquinolones, macrolides, penicillins, and tetracyclines remain core to treatment protocols, while anti-inflammatories and parasiticides address a spectrum of health challenges. Vaccines are gaining traction as a preventive cornerstone, particularly against endemic diseases in high-density operations.

Routes of administration shape clinical adoption and user convenience. Injectable therapies dominate acute interventions, oral formulations support routine dosing, topicals offer localized relief, and inhalation systems are carving out roles in respiratory disease management. Distribution channels extend beyond institutional veterinary hospitals to include retail and online pharmacies, each enabling different levels of product specialization, direct-to-consumer engagement, and logistical flexibility.

Regional Divergence in Veterinary Drug Adoption and Supply Chains

Across the Americas, demand growth is anchored by robust companion animal spending and large-scale livestock operations. North American markets lead in companion health innovation, driving premiumization of therapeutic portfolios. Latin America’s agriculture sector is expanding rapidly, emphasizing immunization and biosecurity to boost meat and dairy exports.

In Europe, the Middle East & Africa, regulatory harmonization efforts are elevating approval standards, while antimicrobial stewardship programs restrict antibiotic usage. This environment accelerates vaccine uptake and the adoption of alternative therapies. Emerging markets in the broader EMEA region are experiencing infrastructure upgrades and increased veterinary service penetration, supporting a more diversified product mix.

Asia-Pacific dynamics are shaped by high-growth aquaculture in Southeast Asia, companion animal proliferation in urban centers, and substantial livestock consumption in South Asia. Governments are intensifying disease surveillance and welfare regulations, prompting manufacturers to localize production and expand distribution networks. Regional trade agreements further influence cross-border flows of active ingredients and finished formulations.

Competitive Landscape and Strategic Moves Among Leading Players

Leading pharmaceutical and biotechnology companies continually refine their positions through acquisitions, licensing deals, and collaborative research programs. Strategic partnerships between large-scale animal health divisions and specialized biotech firms are unlocking access to cutting-edge molecular platforms. At the same time, contract development and manufacturing organizations are scaling facilities to meet evolving formulation and biologics production needs, positioning themselves as critical enablers of both incumbent and emerging players.

Innovators are also investing heavily in digital services, from telemedicine platforms that enhance prescription accuracy to data-driven compliance tools that support antimicrobial stewardship. These value-added offerings differentiate core product lines and deepen customer engagement. Financial stakeholders are betting on companies that demonstrate robust pipelines, diversified distribution strategies, and adaptability to shifting regulatory environments.

Ultimately, the competitive landscape favors organizations that can integrate cross-functional expertise, align therapeutic portfolios with species-specific demands, and navigate the complexities introduced by tariff adjustments and accelerated technological change.

Strategic Actions to Capitalize on Veterinary Market Opportunities

Industry leaders should prioritize integrated R&D portfolios that balance innovative biologics with refined small-molecule therapies. By coupling genomic insights with advanced screening platforms, developers can deliver targeted treatments while meeting antimicrobial stewardship goals. Investment in modular manufacturing systems will facilitate rapid scale-up and responsive production shifts in light of tariff-related sourcing challenges.

Digital transformation remains a critical lever. Establishing telehealth networks and data analytics capabilities enhances customer outreach and drives product adoption, particularly in remote or resource-constrained regions. Partnerships with logistics specialists can improve last-mile delivery, ensuring temperature-sensitive therapies maintain efficacy from factory to farm.

Finally, proactive engagement with regulatory bodies and industry coalitions will help shape stewardship standards and trade policies. By advocating for harmonized guidelines and tariff exemptions on critical inputs, companies can secure more predictable operating conditions. This multi-pronged approach empowers stakeholders to capture growth, optimize margins, and solidify leadership in the veterinary drug ecosystem.

Rigorous Methodological Approach Underpinning the Analysis

Our analysis leverages a dual-track methodology combining extensive secondary research with robust primary validation. Industry literature, regulatory filings, corporate disclosures, and trade data formed the foundation of quantitative insights. These sources were triangulated against financial reports, patent landscapes, and scientific publications to ensure comprehensiveness and accuracy.

Complementing this, structured interviews with veterinarians, procurement managers, R&D leaders, and supply chain experts provided qualitative depth. This stakeholder input illuminated practical challenges and emerging best practices, enriching the interpretation of market segmentation and regional trends. Rigorous data cleansing and cross-verification steps were applied throughout to uphold analytical integrity.

By uniting multiple data streams, the approach delivers a 360-degree perspective that informs strategic planning, risk assessment, and opportunity identification. This transparent, replicable process ensures executive leaders can trust the report’s findings and recommendations.

Synthesizing Insights for Informed Decision-Making in Veterinary Pharma

This executive summary distills the critical trends shaping the veterinary drug domain, from technological innovation and tariff realignment to nuanced segmentation and regional disparities. The combined insights offer a clear pathway for companies to refine their value propositions, streamline operations, and strengthen stakeholder alliances.

As you interpret the competitive and regulatory landscapes, these findings will enable more informed decisions around portfolio development, market entry, and partnership strategies. The actionable recommendations guide resource allocation toward high-potential segments and geographies, while the methodological rigor ensures confidence in strategic planning.

Leveraging this synthesis empowers industry stakeholders to stay ahead of disruption, mitigate emerging risks, and capitalize on the accelerating demand for safe, effective, and sustainable veterinary therapies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Aquaculture
      • Fish
      • Shrimp
    • Companion Animals
      • Canines
      • Felines
    • Equine
    • Livestock
      • Cattle
      • Small Ruminants
      • Swine
    • Poultry
      • Chickens
      • Turkeys
  • Product Category
    • Anti-Infectives
      • Antibiotics
        • Cephalosporins
        • Fluoroquinolones
        • Macrolides
        • Penicillins
        • Tetracyclines
      • Antifungals
      • Antivirals
    • Anti-Inflammatories
    • Parasiticides
    • Vaccines
  • Route Of Administration
    • Inhalation
    • Injectable
    • Oral
    • Topical
  • Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies
    • Veterinary Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • Norbrook Laboratories Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Drug Market, by Animal Type
8.1. Introduction
8.2. Aquaculture
8.2.1. Fish
8.2.2. Shrimp
8.3. Companion Animals
8.3.1. Canines
8.3.2. Felines
8.4. Equine
8.5. Livestock
8.5.1. Cattle
8.5.2. Small Ruminants
8.5.3. Swine
8.6. Poultry
8.6.1. Chickens
8.6.2. Turkeys
9. Veterinary Drug Market, by Product Category
9.1. Introduction
9.2. Anti-Infectives
9.2.1. Antibiotics
9.2.1.1. Cephalosporins
9.2.1.2. Fluoroquinolones
9.2.1.3. Macrolides
9.2.1.4. Penicillins
9.2.1.5. Tetracyclines
9.2.2. Antifungals
9.2.3. Antivirals
9.3. Anti-Inflammatories
9.4. Parasiticides
9.5. Vaccines
10. Veterinary Drug Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.3. Injectable
10.4. Oral
10.5. Topical
11. Veterinary Drug Market, by Distribution Channel
11.1. Introduction
11.2. Online Pharmacies
11.3. Retail Pharmacies
11.4. Veterinary Hospitals
12. Americas Veterinary Drug Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Veterinary Drug Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Veterinary Drug Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Elanco Animal Health Incorporated
15.3.3. Merck & Co., Inc.
15.3.4. Boehringer Ingelheim International GmbH
15.3.5. Ceva Santé Animale S.A.
15.3.6. Virbac S.A.
15.3.7. Phibro Animal Health Corporation
15.3.8. Dechra Pharmaceuticals PLC
15.3.9. Vetoquinol S.A.
15.3.10. Norbrook Laboratories Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VETERINARY DRUG MARKET MULTI-CURRENCY
FIGURE 2. VETERINARY DRUG MARKET MULTI-LANGUAGE
FIGURE 3. VETERINARY DRUG MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VETERINARY DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VETERINARY DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY DRUG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY DRUG MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY DRUG MARKET SIZE, BY SHRIMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY DRUG MARKET SIZE, BY CANINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY DRUG MARKET SIZE, BY FELINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY DRUG MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY DRUG MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY DRUG MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY DRUG MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY DRUG MARKET SIZE, BY CHICKENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY DRUG MARKET SIZE, BY TURKEYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY DRUG MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY DRUG MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY DRUG MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY DRUG MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY DRUG MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY DRUG MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY DRUG MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VETERINARY DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VETERINARY DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VETERINARY DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VETERINARY DRUG MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. CANADA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 73. CANADA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 74. CANADA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 75. CANADA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 76. CANADA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 77. CANADA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 78. CANADA VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 79. CANADA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. MEXICO VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 85. MEXICO VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 87. MEXICO VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 88. MEXICO VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. GERMANY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 135. GERMANY VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 136. GERMANY VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 137. GERMANY VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 138. GERMANY VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 139. GERMANY VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 140. GERMANY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. GERMANY VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. FRANCE VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 146. FRANCE VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 147. FRANCE VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 148. FRANCE VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 149. FRANCE VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. FRANCE VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. ITALY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 164. ITALY VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 165. ITALY VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 166. ITALY VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 167. ITALY VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 168. ITALY VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 169. ITALY VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 170. ITALY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. ITALY VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SPAIN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 174. SPAIN VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 175. SPAIN VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 176. SPAIN VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 177. SPAIN VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 178. SPAIN VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 179. SPAIN VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 180. SPAIN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. SPAIN VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. DENMARK VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 213. DENMARK VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 214. DENMARK VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 215. DENMARK VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 216. DENMARK VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 217. DENMARK VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 218. DENMARK VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 219. DENMARK VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 220. DENMARK VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. DENMARK VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. QATAR VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 233. QATAR VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 234. QATAR VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 235. QATAR VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 236. QATAR VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 237. QATAR VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 238. QATAR VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 239. QATAR VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 240. QATAR VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. QATAR VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. FINLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 243. FINLAND VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 244. FINLAND VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 245. FINLAND VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 246. FINLAND VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 247. FINLAND VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 248. FINLAND VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 249. FINLAND VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 250. FINLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. FINLAND VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. EGYPT VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 273. EGYPT VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 274. EGYPT VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 275. EGYPT VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 276. EGYPT VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 277. EGYPT VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 278. EGYPT VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 279. EGYPT VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 280. EGYPT VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. EGYPT VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. TURKEY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 283. TURKEY VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 284. TURKEY VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 285. TURKEY VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 286. TURKEY VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 287. TURKEY VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 288. TURKEY VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 289. TURKEY VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 290. TURKEY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 291. TURKEY VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. NORWAY VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 303. NORWAY VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 304. NORWAY VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 305. NORWAY VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 306. NORWAY VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 307. NORWAY VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 308. NORWAY VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 309. NORWAY VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 310. NORWAY VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 311. NORWAY VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. POLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 313. POLAND VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 314. POLAND VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 315. POLAND VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 316. POLAND VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 317. POLAND VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 318. POLAND VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 319. POLAND VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 320. POLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. POLAND VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 330. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 331. SWITZERLAND VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 338. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 340. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 343. CHINA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 344. CHINA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 345. CHINA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 346. CHINA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 347. CHINA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 348. CHINA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2030 (USD MILLION)
TABLE 349. CHINA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 350. CHINA VETERINARY DRUG MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 351. CHINA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 352. CHINA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 353. INDIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 354. INDIA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 355. INDIA VETERINARY DRU

Companies Mentioned

The companies profiled in this Veterinary Drug market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • Norbrook Laboratories Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 25.91 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.62 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (November 4, 2025) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (November 4, 2025)

  • Training
  • 1 Day
  • Global
Veterinary Therapeutics Market by Animal Type, Product Type, Route Of Administration, End User, Distribution Channel, Disease Type - Global Forecast to 2030 - Product Image

Veterinary Therapeutics Market by Animal Type, Product Type, Route Of Administration, End User, Distribution Channel, Disease Type - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.